4'-HydroxyflavanoneCAS# 6515-37-3 |
2D Structure
Quality Control & MSDS
3D structure
Package In Stock
Number of papers citing our products
Cas No. | 6515-37-3 | SDF | Download SDF |
PubChem ID | 165506 | Appearance | Powder |
Formula | C15H12O3 | M.Wt | 240.26 |
Type of Compound | Flavonoids | Storage | Desiccate at -20°C |
Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
Chemical Name | 2-(4-hydroxyphenyl)-2,3-dihydrochromen-4-one | ||
SMILES | C1C(OC2=CC=CC=C2C1=O)C3=CC=C(C=C3)O | ||
Standard InChIKey | ZLHVIYHWWQYJID-UHFFFAOYSA-N | ||
Standard InChI | InChI=1S/C15H12O3/c16-11-7-5-10(6-8-11)15-9-13(17)12-3-1-2-4-14(12)18-15/h1-8,15-16H,9H2 | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Description | 4'-Hydroxyflavanone may have major potential as a pharmaceutical preparation against hepatic steatosis and dyslipidemia. 4'-Hydroxyflavanone shows full vasorelaxing effects; it also shows inhibition of nitric oxide production in lipopolysaccharide (LPS)-stimulated product of nitrite in RAW 264.7 cells with the IC50 value of 15.72 ug/mL. |
Targets | NO | SREBPs |
In vitro | Vasorelaxing effects of flavonoids: investigation on the possible involvement of potassium channels.[Pubmed: 15378228 ]Naunyn Schmiedebergs Arch Pharmacol. 2004 Oct;370(4):290-8.A flavonoid-rich diet has been associated with a lower incidence of cardiovascular diseases, probably because of the antioxidant and vasoactive properties of flavonoids. Indeed, many flavonoids show vasorelaxing properties, due to different and often not yet completely clarified mechanisms of action. Among them, the activation of vascular potassium channels has been indicated as a possible pathway, accounting, at least in part, for the vasodilatory action of some flavonoid derivatives, such as apigenin and dioclein. New Diphenol and Isocoumarins from the Aerial Part of Lawsonia inermis and Their Inhibitory Activities against NO Production.[Pubmed: 27689981]Molecules. 2016 Sep 28;21(10).Lawsonia inermis Linn (Lythraceae), also known as henna, is a small shrub or tree distributed throughout Taiwan's Lanyu Island, in North Africa, and in Australia. Its leaves are used as a folk medicine for the treatment of external hemorrhage and fingernail abscesses. |
Kinase Assay | 4'-Hydroxyflavanone suppresses activation of sterol regulatory element-binding proteins and de novo lipid synthesis.[Pubmed: 22634867 ]FEBS Lett. 2012 Jun 21;586(13):1778-82.Sterol regulatory element-binding proteins (SREBPs) are major transcription factors that regulate the expression of genes involved in fatty acid and cholesterol biosynthesis. |
4'-Hydroxyflavanone Dilution Calculator
4'-Hydroxyflavanone Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 4.1622 mL | 20.8108 mL | 41.6216 mL | 83.2432 mL | 104.0539 mL |
5 mM | 0.8324 mL | 4.1622 mL | 8.3243 mL | 16.6486 mL | 20.8108 mL |
10 mM | 0.4162 mL | 2.0811 mL | 4.1622 mL | 8.3243 mL | 10.4054 mL |
50 mM | 0.0832 mL | 0.4162 mL | 0.8324 mL | 1.6649 mL | 2.0811 mL |
100 mM | 0.0416 mL | 0.2081 mL | 0.4162 mL | 0.8324 mL | 1.0405 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- 7-Hydroxyflavanone
Catalog No.:BCN6539
CAS No.:6515-36-2
- Elastase Inhibitor, SPCK
Catalog No.:BCC1226
CAS No.:65144-34-5
- Nicorandil
Catalog No.:BCC5004
CAS No.:65141-46-0
- N-Methylcorydaldine
Catalog No.:BCN3300
CAS No.:6514-05-2
- NGR peptide
Catalog No.:BCC4418
CAS No.:651328-78-8
- Nanchangmycin
Catalog No.:BCC4970
CAS No.:65101-87-3
- Sulfameter
Catalog No.:BCC4855
CAS No.:651-06-9
- L-152,804
Catalog No.:BCC7041
CAS No.:6508-43-6
- 6-Amino-2-methylquinoline
Catalog No.:BCC8759
CAS No.:65079-19-8
- Nimorazole
Catalog No.:BCC5253
CAS No.:6506-37-2
- Boc-His(Tos)-OH.DCHA
Catalog No.:BCC2605
CAS No.:65057-34-3
- VGX-1027
Catalog No.:BCC5203
CAS No.:6501-72-0
- (16R)-Dihydrositsirikine
Catalog No.:BCN4195
CAS No.:6519-26-2
- (16R)-E-Isositsirikine
Catalog No.:BCN4000
CAS No.:6519-27-3
- Avermectin B1a
Catalog No.:BCC1382
CAS No.:65195-55-3
- Avermectin B1b
Catalog No.:BCC1383
CAS No.:65195-56-4
- Isosorbide
Catalog No.:BCC4667
CAS No.:652-67-5
- Gossypin
Catalog No.:BCN7987
CAS No.:652-78-8
- N-Glyceryltaurine
Catalog No.:BCN1753
CAS No.:65222-42-6
- Dehydrocrenatidine
Catalog No.:BCN4196
CAS No.:65236-62-6
- Cucurbitacin B 2-O-beta-D-glucoside
Catalog No.:BCN3119
CAS No.:65247-27-0
- Arvenin II
Catalog No.:BCN7878
CAS No.:65247-28-1
- Ketoconazole
Catalog No.:BCC2272
CAS No.:65277-42-1
- Calhex 231 hydrochloride
Catalog No.:BCC7931
CAS No.:652973-93-8
4'-Hydroxyflavanone suppresses activation of sterol regulatory element-binding proteins and de novo lipid synthesis.[Pubmed:22634867]
FEBS Lett. 2012 Jun 21;586(13):1778-82.
Sterol regulatory element-binding proteins (SREBPs) are major transcription factors that regulate the expression of genes involved in fatty acid and cholesterol biosynthesis. Here we show that 4'-hydroxyflavanone (4'-HF) impairs the fatty acid synthase promoter activity and reduces the activation of SREBPs and their target gene expression in human hepatoma Huh-7 cells. Moreover, 4'-HF suppresses de novo fatty acid and cholesterol synthesis. This study identifies 4'-HF as an inhibitor of SREBP maturation and lipid synthesis, and provides evidence that 4'-HF may have major potential as a pharmaceutical preparation against hepatic steatosis and dyslipidemia.
New Diphenol and Isocoumarins from the Aerial Part of Lawsonia inermis and Their Inhibitory Activities against NO Production.[Pubmed:27689981]
Molecules. 2016 Sep 28;21(10). pii: molecules21101299.
Lawsonia inermis Linn (Lythraceae), also known as henna, is a small shrub or tree distributed throughout Taiwan's Lanyu Island, in North Africa, and in Australia. Its leaves are used as a folk medicine for the treatment of external hemorrhage and fingernail abscesses. Investigation of the ethyl acetate (EtOAc)-soluble fractions from methanol extract of the aerial part of Lawsonia inermis has led to the isolation of a new diphenol, (Z)-4,4'-(prop-1-ene-1,3-diyl)diphenol (1), two new isocoumarin carbonates, inermiscarbonates A (2) and B (3), and six known compounds, 4'-hydroxyflavanone (4), apigenine (5), kampferol (6), luteolin (7), quercetin (8), and (-)-catechin (9). Their structures were determined by detailed analysis of spectroscopic data and comparison with the data of known analogues. Compounds 1 and 4-9 were evaluated for the inhibition of nitric oxide production in lipopolysaccharide (LPS)-stimulated product of nitrite in RAW 264.7 cells with IC50 values of 5.63, 15.72, 8.67, 6.67, 6.17, 7.61, and 14.52 mug/mL, respectively.
Vasorelaxing effects of flavonoids: investigation on the possible involvement of potassium channels.[Pubmed:15378228]
Naunyn Schmiedebergs Arch Pharmacol. 2004 Oct;370(4):290-8.
A flavonoid-rich diet has been associated with a lower incidence of cardiovascular diseases, probably because of the antioxidant and vasoactive properties of flavonoids. Indeed, many flavonoids show vasorelaxing properties, due to different and often not yet completely clarified mechanisms of action. Among them, the activation of vascular potassium channels has been indicated as a possible pathway, accounting, at least in part, for the vasodilatory action of some flavonoid derivatives, such as apigenin and dioclein. Therefore, this work aims at evaluating, on in vitro isolated rat aortic rings, the endothelium-independent vasorelaxing effects of a number of flavonoid derivatives, to identify a possible activation of calcium-activated and/or ATP-sensitive potassium channels and to indicate some possible structure-activity relationships. Among the several flavonoids submitted to the pharmacological assay, only baicalein and quercetagetin were almost completely ineffective, while quercetin, hesperidin, quercitrin and rhoifolin exhibited only a partial vasorelaxing effect. On the contrary, acacetin, apigenin, chrysin, hesperetin, luteolin, pinocembrin, 4'-hydroxyflavanone, 5-hydroxyflavone, 5-methoxyflavone, 6-hydroxyflavanone and 7-hydroxyflavone, belonging to the chemical classes of flavones and flavanones, showed full vasorelaxing effects. The vasodilatory activity of hesperetin, luteolin, 5-hydroxyflavone and 7-hydroxyflavone were antagonised by tetraethylammonium chloride, indicating the possible involvement of calcium-activated potassium channels. Moreover, iberiotoxin clearly antagonised the effects of 5-hydroxyflavone, indicating the probable importance of a structural requirement (the hydroxy group in position 5) for a possible interaction with large-conductance, calcium-activated potassium channels. Finally, glibenclamide inhibited the vasorelaxing action of luteolin and 5-hydroxyflavone, suggesting that ATP-sensitive potassium channels may also be involved in their mechanism of action.